CLSD Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-01-20 | Ciulla Thomas | officer: Chief Medical Officer | 291,890 | S-Sale | D | 13,700 | 1.47 | 20,139.00 |
| 2023-01-19 | Deignan Charles A. | officer: Chief Financial Officer | 363,472 | S-Sale | D | 14,030 | 1.50 | 21,045.00 |
| 2023-01-19 | LASEZKAY GEORGE M | director, officer: CEO | 484,577 | S-Sale | D | 20,030 | 1.46 | 29,243.80 |
| 2023-01-10 | Ciulla Thomas | officer: Chief Medical Officer | 305,590 | S-Sale | D | 2,170 | 1.62 | 3,515.40 |
| 2023-01-04 | Ciulla Thomas | officer: Chief Medical Officer | 187,500 | A-Award | A | 187,500 | 1.48 | 277,500.00 |
| 2023-01-04 | Deignan Charles A. | officer: Chief Financial Officer | 187,500 | A-Award | A | 187,500 | 1.48 | 277,500.00 |
| 2023-01-04 | LASEZKAY GEORGE M | director, officer: CEO | 487,500 | A-Award | A | 487,500 | 1.48 | 721,500.00 |
| 2022-12-31 | Ciulla Thomas | officer: Chief Medical Officer | 307,760 | A-Award | A | 5,000 | 0.95 | 4,750.00 |
| 2022-12-21 | Thorp Clay | director | 30,522 | P-Purchase | A | 14,000 | 1.02 | 14,266.00 |
| 2022-12-20 | Deignan Charles A. | officer: Chief Financial Officer | 0 | M-Exempt | D | 23,636 | 0.40 | 9,454.40 |
| 2022-12-20 | Deignan Charles A. | officer: Chief Financial Officer | 377,502 | M-Exempt | A | 23,636 | 0.40 | 9,454.40 |
| 2022-12-15 | Thorp Clay | director | 16,522 | J-Other | A | 8,522 | 0.00 | 0.00 |
| 2022-12-15 | Thorp Clay | director | 3,545,040 | J-Other | D | 1,406,507 | 0.00 | 0.00 |
| 2022-11-17 | Hutson Nancy J | director | 83,000 | P-Purchase | A | 30,000 | 1.33 | 39,900.00 |
| 2022-06-30 | Ciulla Thomas | officer: Chief Medical Officer | 302,760 | A-Award | A | 5,000 | 1.25 | 6,250.00 |
| 2022-06-22 | SHAFFER CHRISTY L | director | 30,000 | A-Award | A | 30,000 | 1.62 | 48,600.00 |
| 2022-06-22 | YERXA BENJAMIN R | director | 30,000 | A-Award | A | 30,000 | 1.62 | 48,600.00 |
| 2022-06-22 | Croarkin Richard | director | 30,000 | A-Award | A | 30,000 | 1.62 | 48,600.00 |
| 2022-06-22 | Hutson Nancy J | director | 30,000 | A-Award | A | 30,000 | 1.62 | 48,600.00 |
| 2022-06-22 | EDWARDS JEFFREY L | director | 30,000 | A-Award | A | 30,000 | 1.62 | 48,600.00 |
| 2022-06-22 | Thorp Clay | director | 30,000 | A-Award | A | 30,000 | 1.62 | 48,600.00 |
| 2022-06-22 | Humphries William D. | director | 30,000 | A-Award | A | 30,000 | 1.62 | 48,600.00 |
| 2022-03-02 | YERXA BENJAMIN R | director | 30,000 | A-Award | A | 30,000 | 1.49 | 44,700.00 |
| 2022-01-19 | Deignan Charles A. | officer: Chief Financial Officer | 131,250 | A-Award | D | 131,250 | 2.19 | 287,437.50 |
| 2022-01-19 | Deignan Charles A. | officer: Chief Financial Officer | 351,366 | S-Sale | D | 8,833 | 2.09 | 18,460.97 |
| 2022-01-19 | LASEZKAY GEORGE M | director, officer: CEO | 292,500 | A-Award | D | 292,500 | 2.19 | 640,575.00 |
| 2022-01-19 | LASEZKAY GEORGE M | director, officer: CEO | 504,607 | S-Sale | D | 10,800 | 2.12 | 22,896.00 |
| 2022-01-19 | Ciulla Thomas | officer: Chief Medical Officer | 131,250 | A-Award | D | 131,250 | 2.19 | 287,437.50 |
| 2022-01-19 | Ciulla Thomas | officer: Chief Medical Officer | 295,260 | S-Sale | D | 9,050 | 2.13 | 19,276.50 |
| 2022-01-18 | Deignan Charles A. | officer: Chief Financial Officer | 138,750 | A-Award | A | 138,750 | 2.19 | 303,862.50 |
| 2022-01-18 | Deignan Charles A. | officer: Chief Financial Officer | 362,699 | A-Award | A | 46,250 | 0.00 | 0.00 |
| 2022-01-18 | Ciulla Thomas | officer: Chief Medical Officer | 138,750 | A-Award | A | 138,750 | 2.19 | 303,862.50 |
| 2022-01-18 | Ciulla Thomas | officer: Chief Medical Officer | 301,810 | A-Award | A | 46,250 | 0.00 | 0.00 |
| 2022-01-18 | Deignan Charles A. | officer: Chief Financial Officer | 360,199 | A-Award | A | 43,750 | 0.00 | 0.00 |
| 2022-01-18 | LASEZKAY GEORGE M | director, officer: CEO | 515,407 | A-Award | A | 97,500 | 0.00 | 0.00 |
| 2022-01-18 | Ciulla Thomas | officer: Chief Medical Officer | 299,310 | A-Award | A | 43,750 | 0.00 | 0.00 |
| 2022-01-11 | LASEZKAY GEORGE M | director, officer: CEO | 417,907 | S-Sale | D | 5,100 | 2.46 | 12,546.00 |
| 2022-01-10 | Humphries William D. | director | 0 | M-Exempt | D | 22,727 | 0.15 | 3,409.05 |
| 2022-01-10 | Humphries William D. | director | 28,313 | M-Exempt | A | 22,727 | 0.15 | 3,409.05 |
| 2021-10-29 | Hutson Nancy J | director | 15,000 | M-Exempt | D | 15,000 | 2.09 | 31,350.00 |
| 2021-10-29 | Hutson Nancy J | director | 0 | M-Exempt | D | 25,000 | 2.00 | 50,000.00 |
| 2021-10-29 | Hutson Nancy J | director | 53,000 | M-Exempt | A | 15,000 | 2.09 | 31,350.00 |
| 2021-10-29 | Hutson Nancy J | director | 38,000 | M-Exempt | A | 25,000 | 2.00 | 50,000.00 |
| 2021-09-21 | Deignan Charles A. | officer: Chief Financial Officer | 316,449 | S-Sale | D | 2,800 | 6.41 | 17,948.00 |
| 2021-09-21 | LASEZKAY GEORGE M | director, officer: CEO | 423,007 | S-Sale | D | 3,525 | 6.46 | 22,771.50 |
| 2021-09-21 | Ciulla Thomas | officer: Chief Medical Officer | 255,560 | S-Sale | D | 2,560 | 6.40 | 16,384.00 |
| 2021-09-01 | WHITMORE BRADFORD T | 10 percent owner | 2,415,056 | S-Sale | D | 213,203 | 6.89 | 1,469,245.83 |
| 2021-08-31 | WHITMORE BRADFORD T | 10 percent owner | 2,628,259 | S-Sale | D | 107,682 | 6.96 | 749,079.06 |
| 2021-08-30 | WHITMORE BRADFORD T | 10 percent owner | 2,735,941 | S-Sale | D | 99,400 | 7.06 | 702,101.96 |
| 2021-08-16 | Hutson Nancy J | director | 13,000 | P-Purchase | A | 3,000 | 5.68 | 17,040.00 |
| 2021-06-21 | Deignan Charles A. | officer: Chief Financial Officer | 319,249 | S-Sale | D | 2,938 | 4.37 | 12,839.06 |
| 2021-06-21 | LASEZKAY GEORGE M | director, officer: CEO | 426,532 | S-Sale | D | 3,707 | 4.38 | 16,236.66 |
| 2021-06-10 | SHAFFER CHRISTY L | director | 25,000 | A-Award | A | 25,000 | 3.11 | 77,750.00 |
| 2021-06-10 | Humphries William D. | director | 25,000 | A-Award | A | 25,000 | 3.11 | 77,750.00 |
| 2021-06-10 | EDWARDS JEFFREY L | director | 25,000 | A-Award | A | 25,000 | 3.11 | 77,750.00 |
| 2021-06-10 | Croarkin Richard | director | 25,000 | A-Award | A | 25,000 | 3.11 | 77,750.00 |
| 2021-06-10 | Hutson Nancy J | director | 25,000 | A-Award | A | 25,000 | 3.11 | 77,750.00 |
| 2021-06-10 | Thorp Clay | director | 25,000 | A-Award | A | 25,000 | 3.11 | 77,750.00 |
| 2021-03-19 | LASEZKAY GEORGE M | director, officer: CEO | 430,239 | S-Sale | D | 3,370 | 2.82 | 9,503.40 |
| 2021-03-12 | Hutson Nancy J | director | 10,000 | P-Purchase | A | 5,000 | 3.11 | 15,525.00 |
| 2021-03-02 | LASEZKAY GEORGE M | director, officer: CEO | 433,609 | S-Sale | D | 6,000 | 3.37 | 20,220.00 |
| 2021-03-01 | Ciulla Thomas | officer: Chief Medical Officer | 40,000 | A-Award | A | 40,000 | 5.04 | 201,600.00 |
| 2021-02-10 | Thorp Clay | director | 3,433,521 | S-Sale | D | 32,873 | 4.43 | 145,627.39 |
| 2021-01-18 | Ciulla Thomas | officer: Chief Medical Officer | 253,122 | A-Award | A | 103,125 | 0.00 | 0.00 |
| 2021-01-18 | Ciulla Thomas | officer: Chief Medical Officer | 209,375 | A-Award | A | 209,375 | 4.01 | 839,593.75 |
| 2021-01-18 | LASEZKAY GEORGE M | director, officer: CEO | 439,609 | A-Award | A | 140,250 | 0.00 | 0.00 |
| 2021-01-18 | LASEZKAY GEORGE M | director, officer: CEO | 284,750 | A-Award | A | 284,750 | 4.01 | 1,141,847.50 |
| 2021-01-18 | Deignan Charles A. | officer: Chief Financial Officer | 322,187 | A-Award | A | 96,360 | 0.00 | 0.00 |
| 2021-01-18 | Deignan Charles A. | officer: Chief Financial Officer | 195,640 | A-Award | A | 195,640 | 4.01 | 784,516.40 |
| 2021-01-06 | WHITMORE BRADFORD T | 10 percent owner | 3,529,845 | P-Purchase | A | 350,750 | 2.85 | 999,988.25 |
| 2020-12-24 | WHITMORE BRADFORD T | 10 percent owner | 3,179,095 | P-Purchase | A | 51,195 | 1.95 | 99,896.80 |
| 2020-12-21 | LASEZKAY GEORGE M | director, officer: CEO | 299,359 | S-Sale | D | 3,330 | 2.07 | 6,893.10 |
| 2020-12-02 | WHITMORE BRADFORD T | 10 percent owner | 3,127,900 | P-Purchase | A | 53,900 | 1.95 | 105,051.10 |
| 2020-11-24 | WHITMORE BRADFORD T | 10 percent owner | 3,074,000 | P-Purchase | A | 62,000 | 1.65 | 102,045.80 |
| 2020-11-16 | WHITMORE BRADFORD T | 10 percent owner | 3,012,000 | P-Purchase | A | 62,000 | 1.69 | 104,928.80 |
| 2020-09-22 | LASEZKAY GEORGE M | director, officer: CEO | 302,689 | S-Sale | D | 13,411 | 1.59 | 21,323.49 |
| 2020-08-18 | Humphries William D. | director | 5,586 | P-Purchase | A | 5,586 | 1.78 | 9,943.08 |
| 2020-08-13 | WHITMORE BRADFORD T | 10 percent owner | 2,950,000 | P-Purchase | A | 50,000 | 1.65 | 82,560.00 |
| 2020-08-12 | WHITMORE BRADFORD T | 10 percent owner | 2,900,000 | P-Purchase | A | 300,000 | 1.63 | 489,120.00 |
| 2020-06-18 | Hutson Nancy J | director | 25,000 | A-Award | A | 25,000 | 2.00 | 50,000.00 |
| 2020-06-18 | Humphries William D. | director | 25,000 | A-Award | A | 25,000 | 2.00 | 50,000.00 |
| 2020-06-18 | Croarkin Richard | director | 25,000 | A-Award | A | 25,000 | 2.00 | 50,000.00 |
| 2020-06-18 | EDWARDS JEFFREY L | director | 25,000 | A-Award | A | 25,000 | 2.00 | 50,000.00 |
| 2020-06-18 | SHAFFER CHRISTY L | director | 25,000 | A-Award | A | 25,000 | 2.00 | 50,000.00 |
| 2020-06-18 | Thorp Clay | director | 25,000 | A-Award | A | 25,000 | 2.00 | 50,000.00 |
| 2020-06-01 | Deignan Charles A. | officer: Chief Financial Officer | 220,827 | S-Sale | D | 14,992 | 1.88 | 28,184.96 |
| 2020-05-20 | Hutson Nancy J | director | 5,000 | P-Purchase | A | 5,000 | 1.85 | 9,250.00 |
| 2020-05-12 | LASEZKAY GEORGE M | director, officer: CEO | 311,100 | S-Sale | D | 32,150 | 1.99 | 63,978.50 |
| 2020-04-21 | Hutson Nancy J | director | 30,000 | A-Award | A | 30,000 | 2.09 | 62,700.00 |
| 2020-03-11 | LASEZKAY GEORGE M | director, officer: CEO | 343,250 | A-Award | A | 50,000 | 0.00 | 0.00 |
| 2020-01-08 | LASEZKAY GEORGE M | director, officer: CEO | 288,250 | A-Award | A | 66,250 | 0.00 | 0.00 |
| 2020-01-08 | LASEZKAY GEORGE M | director, officer: CEO | 198,750 | A-Award | A | 198,750 | 2.37 | 471,037.50 |
| 2020-01-08 | Deignan Charles A. | officer: Chief Financial Officer | 228,856 | A-Award | A | 25,000 | 0.00 | 0.00 |
| 2020-01-08 | Deignan Charles A. | officer: Chief Financial Officer | 75,000 | A-Award | A | 75,000 | 2.37 | 177,750.00 |
| 2019-11-22 | Thorp Clay | director | 4,984,420 | A-Award | A | 1,518,026 | 1.05 | 1,599,999.40 |
| 2019-11-12 | Deignan Charles A. | officer: Chief Financial Officer | 203,856 | P-Purchase | A | 7,500 | 1.14 | 8,550.00 |
| 2019-11-11 | LASEZKAY GEORGE M | director, officer: CEO | 222,000 | P-Purchase | A | 12,000 | 1.16 | 13,920.00 |
| 2019-09-18 | Deignan Charles A. | officer: Chief Financial Officer | 196,356 | A-Award | A | 70,000 | 0.00 | 0.00 |
| 2019-09-18 | LASEZKAY GEORGE M | director, officer: CEO | 210,000 | A-Award | A | 110,000 | 0.00 | 0.00 |
| 2019-08-07 | LASEZKAY GEORGE M | director, officer: CEO | 100,000 | A-Award | A | 100,000 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.